These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1297640)

  • 41. Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Final report at 5 years: prognostic value of various measures.
    Tam CM; Chan SL; Kam KM; Goodall RL; Mitchison DA
    Int J Tuberc Lung Dis; 2002 Jan; 6(1):3-10. PubMed ID: 11931398
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Advanced stage of chronic kidney disease is risk of poor treatment outcome for smear-positive pulmonary tuberculosis.
    Igari H; Imasawa T; Noguchi N; Nagayoshi M; Mizuno S; Ishikawa S; Kadomura M; Nishimura M; Yamagishi F
    J Infect Chemother; 2015 Aug; 21(8):559-63. PubMed ID: 26048063
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of hepatic failure secondary to isoniazid hepatitis with liver transplantation.
    Farrell FJ; Keeffe EB; Man KM; Imperial JC; Esquivel CO
    Dig Dis Sci; 1994 Oct; 39(10):2255-9. PubMed ID: 7924752
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Five-year follow-up of a clinical trial of three 6-month regimens of chemotherapy given intermittently in the continuation phase in the treatment of pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
    Am Rev Respir Dis; 1988 May; 137(5):1147-50. PubMed ID: 2904237
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Short-course treatment of tuberculosis on a 7-month schedule with an initial intensive phase of 1 month (TA-81)].
    Farga V; Valenzuela P; Yañez A; Valenzuela MT; Scheel G; Mendoza F; Torres E; Icekson I; Grinspun M; Fernández M
    Rev Med Chil; 1984 Mar; 112(3):290-5. PubMed ID: 6473971
    [No Abstract]   [Full Text] [Related]  

  • 46. An unusual case of chylothorax complicating childhood tuberculosis.
    Cakir E; Gocmen B; Uyan ZS; Oktem S; Kiyan G; Karakoc F; Ersu R; Karadag B; Dagli T; Dagli E
    Pediatr Pulmonol; 2008 Jun; 43(6):611-4. PubMed ID: 18433047
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The tolerability and efficacy of a 6-month antituberculosis regimen containing rifampicin, isoniazid and pyrazinamide.
    Kleeberg HH; Swart DJ; Carey SM
    S Afr Med J; 1983 Oct; 64(18):693-6. PubMed ID: 6623275
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Advances in the treatment of tuberculosis.
    Clarke PD
    J R Nav Med Serv; 1976; 62(2):85-91. PubMed ID: 61273
    [No Abstract]   [Full Text] [Related]  

  • 49. Short-course chemotherapy for pulmonary tuberculosis.
    Fox W; Mitchison DA
    Am Rev Respir Dis; 1975 Mar; 111(3):325-53. PubMed ID: 47233
    [No Abstract]   [Full Text] [Related]  

  • 50. Outpatient management of tuberculosis.
    McColloster P; Neff NE
    Am Fam Physician; 1996 Apr; 53(5):1579-94. PubMed ID: 8623687
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Controlled clinical trial of two 6-month regimens of chemotherapy in the treatment of pulmonary tuberculosis. Tanzania/British Medical Research Council Study.
    Am Rev Respir Dis; 1985 May; 131(5):727-31. PubMed ID: 3890640
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early bactericidal activity of ethambutol, pyrazinamide and the fixed combination of isoniazid, rifampicin and pyrazinamide (Rifater) in patients with pulmonary tuberculosis.
    Botha FJ; Sirgel FA; Parkin DP; van de Wal BW; Donald PR; Mitchison DA
    S Afr Med J; 1996 Feb; 86(2):155-8. PubMed ID: 8619142
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The treatment of multidrug-resistant tuberculosis in Turkey.
    Tahaoğlu K; Törün T; Sevim T; Ataç G; Kir A; Karasulu L; Ozmen I; Kapakli N
    N Engl J Med; 2001 Jul; 345(3):170-4. PubMed ID: 11463011
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rifampin in initial treatment of pulmonary tuberculosis. A.U.S. Public Health Service tuberculosis therapy trial.
    Newman R; Doster BE; Murray FJ; Woolpert SF
    Am Rev Respir Dis; 1974 Feb; 109(2):216-32. PubMed ID: 4204541
    [No Abstract]   [Full Text] [Related]  

  • 55. Drugs for tuberculosis.
    Med Lett Drugs Ther; 1995 Aug; 37(954):67-70. PubMed ID: 7616907
    [No Abstract]   [Full Text] [Related]  

  • 56. CDC recommends four-drug treatment of tuberculosis in multidrug-resistant era.
    Am Fam Physician; 1993 Sep; 48(4):671-2. PubMed ID: 8397483
    [No Abstract]   [Full Text] [Related]  

  • 57. [Therapeutic effect of ofloxacin on intractable pulmonary tuberculosis and ofloxacin resistance of tubercle bacilli isolated from the patients. Chest DIsease Cooperative Study Unit of National Sanatoriums in Kinki District].
    Nakae I; Nakatani K; Inoue S; Takahasi K; Ikeda N; Matsumoto T; Ozawa S; Sakatani M; Kita N; Tanaka S
    Kekkaku; 1991 Apr; 66(4):299-307. PubMed ID: 1904960
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Pulmonary tuberculosis resistant to streptomycin and isoniazid and treated wtih a combination of ethionamide, pyrazinamide, and cycloserine (200 cases)].
    Bartal M; Nejjar A; Laraki A
    Tunis Med; 1973 Jul; 51(4):237-43. PubMed ID: 4209977
    [No Abstract]   [Full Text] [Related]  

  • 59. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Combined chemotherapy of patients with tuberculosis - new regimens and dosage forms].
    Sokolova GB; Koriakin VA; Khalbaeva IV; Elistratova NA; Ziia AV
    Probl Tuberk; 1993; (5):21-3. PubMed ID: 8295879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.